Bellevue Group AG

Position in VRDN — Viridian Therapeutics, Inc.DE

CIK 1674546 Zurich, V8

Position in VRDN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$131,563,376

-$4,073,984 QoQ

Shares Held

6,726,144

+54.3% QoQ

Ownership

6.53%

of shares outstanding

% of Portfolio

3.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bellevue Group AG holds $2,583,944,637 across 59 Biotechnology names. VRDN ranks #7 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	681,908	$304,499,197
2	ARGX	Argenx SE	313,000	$228,568,250
3	REGN	Regeneron Pharmaceuticals, Inc.	278,674	$215,314,678
4	SRRK	Scholar Rock Holding Corp	3,584,573	$176,217,608
5	RVMD	Revolution Medicines, Inc.	1,544,456	$150,198,346
6	IONS	Ionis Pharmaceuticals Inc	1,818,665	$136,563,554
7	VRDN	Viridian Therapeutics, Inc.DE This page	6,726,144	$131,563,376
8	KRYS	Krystal Biotech, Inc.	481,785	$124,454,701

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$131,563,376	6,726,144	0.0%	Shares	Sole	2026-05-15
2026-03-31	$131,563,376	6,726,144	+54.3%	Shares	Defined	2026-05-15
2025-12-31	$135,637,360	4,358,527	+22719.5%	Shares	Defined	2026-02-17
2024-03-31	$334,441	19,100	-36.3%	Shares	Defined	2024-05-15
2023-12-31	$653,400	30,000	-53.0%	Shares	Defined	2024-02-14
2023-09-30	$978,231	63,770	+43.6%	Shares	Defined	2023-11-14
2023-06-30	$1,056,276	44,400	-3.7%	Shares	Defined	2023-08-14
2023-03-31	$1,172,784	46,100	0.0%	Shares	Defined	2023-05-15
2022-12-31	$1,346,581	46,100	0.0%	Shares	Defined	2023-02-14
2022-09-30	$945,511	46,100	-5.9%	Shares	Defined	2022-11-14
2022-06-30	$566,930	49,000	—	Shares	Defined	2022-08-11
No filing history on record for this holder in this stock.